Dr. Reddy's Laboratories Ltd.

500124

Equity

ISIN INE089A01031 / Valor 138953781

Bombay Stock Exchange Ltd. (Mumbai) (2026-10-16)

INR 1,231.85+0.91%

Dr. Reddy's Laboratories Ltd.
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Dr. Reddy's Laboratories Ltd., headquartered in Hyderabad, India, is a multinational pharmaceutical company with core businesses in generics (branded and unbranded, including biosimilars), active pharmaceutical ingredients (APIs) and services (development, manufacturing and research support), innovative medicines and consumer health products; it also grows its portfolio through in‑licensing and partnerships. The company has commercialized a bevacizumab biosimilar in the UK, is collaborating with Gilead Sciences to manufacture and commercialize the long‑acting HIV treatment lenacapavir across multiple countries, and has brought an approved immunotherapy for recurrent or metastatic nasopharyngeal carcinoma into the Indian market, reflecting a strategic mix of generic manufacturing, specialty biologics and partnership‑led innovation.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-0.66%1Y

12.2%3Y

24.2%5Y

Performance

23.3%1Y

21.8%3Y

21.6%5Y

Volatility